North America holds a notable share of the human rabies immunoglobulin market, driven by high awareness regarding rabies prevention, robust healthcare spending, and established treatment guidelines for post-exposure prophylaxis. The region benefits from strong pharmaceutical manufacturing capabilities, advanced healthcare facilities, and ongoing public health initiatives focused on infectious...

The US Safety Lancet Market growth continues to expand as clinical laboratories and blood collection services implement comprehensive sharps safety programs that exceed baseline regulatory requirements. The Centers for Disease Control and Prevention estimates that approximately 385,000 needlestick injuries occur annually among healthcare workers in US hospitals, driving institutional commitment...